Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate

Brain Research

Volumn 728, Issue 2, 1996, Pages 193-203

  Charles, Vinod ^a   Mufson, Elliott J ^a   Friden, Phillip M ^b,c   Bartus, Raymond T ^b   Kordower, Jeffrey H ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b ALKERMES INC   (United States)

^c Periodontix Inc   (United States)

Author keywords

Blood brain barrier; Cholinergic; Excitotoxicity; Nerve growth factor; Nucleus basalis; Regeneration

Indexed keywords

EXCITOTOXIN; N METHYL DEXTRO ASPARTIC ACID; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN INJURY; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; FOREBRAIN; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030605874     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00398-8     Document Type: Article

References (63)

1. [1] Backman, C., Biddle, P.T., Ebendal, T., Friden, P.M., Gerhardt, G.A., Henry, M.A., Mackerlova, L., Soderstrom, S., Stromberg, I., Walus, L. and Granholm, A.-C., Effects of transferrin receptor antibody-NGF conjugate on young and aged septal transplants in oculo, Exp Neurol., 132 (1995) 1-15.
2. [2] Backman, C., Granholm, A.-C., Bartus, R., Henry, M., Hoffer, B. and Rose, G., Anti-transferrin receptor antibody-NGF conjugate improves spatial memory and ameliorates cholinergic neuron atrophy in aged rats, Soc. Neurosci. Abstr., 227.5, (1995) 548 pp.
3. [3] Barbacid, M., The trk family of neurotrophin receptors: molecular characterization and oncogenic activation in human tumors. In A.J. Levine and H.H. Schmidek (Eds.), Wiley & Sons, Inc., New York, 1993, pp. 123-135.
4. [4] Barbacid, M., The trk family of neurotrophin receptors, J. Neurobiol., 25 (1994) 1386-1403.
5. [5] Bartus, R.T., Dean, R.L., Beer, B. and Lippa, A.S., The cholinergic hypothesis of geriatric memory dysfunction, Science, 217 (1992) 408-417.
6. [6] Bothwell, M., Keeping track of neurotrophin receptors, Cell, 65 (1991) 915-918.
7. [7] Chao, M.V., The p75 neurotrophin receptor, J. Neurobiol., 25 (1994) 1373-1385.
8. [8] Chao, M.V. and Hempstead, B.L., p75 and Trk: a two-receptor system, Trends Neurosci., 18 (1995) 321-326.
9. [9] Chen, K.S. and Gage, F.H., Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration, J. Neurosci., 4 (1995) 2819-2825.
10. [10] Cooper, J.D., Lindholm, D. and Sofroniew, M.V., Reduced transport of [125] nerve growth factor to cholinergic neurons and down regulated trk-expression in the medial septum of rats, Neuroscience, 62 (1995) 625-629.
11. [11] Ebendal, T., Function and evolution in the NGF family and its receptors, J. Neurol. Res., 32 (1992) 461-470.
12. [12] Emerich, D.F., Winn, S.R., Hammang, J.P., Baetge, E.E. and Kordower, J.H., Grafts of polymer-encapsulated cells genetically modified to secrete nerve growth factor rescue basal forebrain neurons in nonhuman primates, J. Comp. Neurol., 349 (1994) 148-165.
13. [13] Figueiredo, B.C., Skup, M., Bedard, A.M., Tetzlaff, W. and Cuello, A.C., Differential expression of p140trk, p75NGFr, and growth-associated phosphoprotein-43 genes in nucleus basalis magnocellularis, thalamus, and adjacent cortex following neocortical infarction and nerve growth factor treatment, Neuroscience, 68 (1995) 29-45.
14. [14] Fischer, W., Wictorin, K., Bjorklund, A., Williams, L.R., Varon, S. and Gage, F.H., Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor, Nature, 329 (1987) 65-68.
15. [15] Friden, P.M., Walus, L.R., Watson, P., Doctrow, S.R., Kozarich, J.W., Backman, C., Bergman, H., Hoffer, B., Bloom, F. and Granholm, A.C., Blood-brain barrier penetration and in vivo activity of an NGF conjugate, Science, 259 (1993) 373-377.
16. [16] Friden, P.M., Walus, L.R., Musso, G.F., Taylor, M.A., Malfroy, B. and Starzyk, R.M., Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier., Proc. Natl. Acad. Sci. USA, 88 (1991) 4771-4775.
17. [17] Gage, F.H., Batchelor, P., Chen, K.S., Chin, D., Higgins, G.A., Koh, S. Deputy, S., Rosenberg, M.B., Fischer, W. and Bjorklund, A., NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum, Neuron, 2 (1989) 1177-1184.
18. [18] Gibbs, R.B. and Pfaff, D.W., In situ hybridization detection of trkA mRNA in brain: Distribution, colocalization with p75NGFr and up-regulation by nerve growth factor, J. Comp. Neurol., 341 (1994) 324-339.
19. [19] Granholm, A.C., Backman, C., Bloom, F., Ebendal, T., Gerhardt, G.A., Hoffer, B., Mackerlova, L., Olson, L., Soderstrom, S., Walus, L.R. and Friden, P.M., NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants, J Pharmacol. Exp., Ther., 268 (1994) 448-459.
20. [20] Hefti, F., Hartikka, J., Salviaterra, P., Weiner, W.J. and Mash, D.C., Localization of nerve growth factor receptors on cholinergic neurons of the human basal forebrain, Neurosci. Lett., 69 (1986) 275-281.
21. [21] Hefti, F. and Mash D.C., Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease, Neurobiol. Aging, 10 (1989) 75-87.
22. [22] Hefti, F., Hartikka, J. and KnuseL B., Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative disease, Neurobiol. Aging, 10 (1989) 515-533.
23. [23] Higgins, G.A. and Mufson, E.J., NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease, Exp. Neurol., 106 (1989) 222-236.
24. [24] Holtzman, D.M., Kilbridge, J., Li, Y., Cunningham, Jr., E.T., Lenn, N.J., Clary, D.O., Reichardt, L.F. and Mobley, W.C., TrkA expression in the CNS: Evidence for the existence of several novel NGF-responsive CNS neurons, J. Neurosci., 15 (1995) 1567-1676.
25. [25] Holtzman, D.M., Chen, K.S., Gage, F.H., Epstein, C.J. and Mobley, W.C., Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration, Neurology, 43 (1993) 2668-2673.
26. [26] Hsu, S.M., Raine, L. and Fanger, H., Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures, J. Histochem. Cytochem., 29 (1981) 577-580.
27. [27] Johnston, M.V., Rutkowski, J.L., Wainer, B.H., Long, J.B., Mobley, W.C., NGF effects on developing forebrain cholinergic neurons are regionally specific, Neurochem. Res., 12 (1987) 985-994.
28. [28] Kawaja, M.D., Rosenberg, M.B., Yoshida, K. and Gage, F.H., Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of the axons in adult rats, J. Neurosci., 12 (1992) 2849-2864.
29. [29] Kokaia, Z., Bengzon, J., Metsis, M., Kokaia, M., Persson, H. and Lindvall, O., Coexpression of neurotrophins and their receptors in neurons of the central nervous system, Proc. Natl. Acad. Sci. USA, 90 (1993) 6711-6715.
30. [30] Koliatsos, V.E., Price, D.L., Gouras, G.K., Cayouette, M.H., Burton, L.E. and Winslow, J.W., Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons, J. Comp. Neurol., 343 (1994) 247-262.
31. [31] Kordower, J.H., Bartus, R.T., Bothwell, M., Schatteman, G. and Gash, D.M., Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus appella): Distribution, Morphology, and colocalization with cholinergic enzymes, J. Comp. Neurol., 277 (1988) 465-486.
32. [32] Kordower, J.H., Gash, D.M., Bothwell, M., Hersh, L.B. and Mufson, E.J., Nerve growth factor receptor and choline acetyltransferase remain colocahzed in the nucleus basalis (Ch4) of Alzheimer's patients, Neurobiol. Aging, 10 (1989) 287-294.
33. [33] Kordower, J.H., Winn, S.R., Liu, Y.-T., Mufson, E.J., Sladek, J.R., Hammang, J.P., Baetge, E.E. and Emerich, D.F., The aged monkey basal forebrain: rescue and sprouting of degenerating cholinergic neurons following grafts of polymer-encapsulated human NGF secreting cells, Proc. Natl. Acad. Sci. USA, 91 (1994) 10898-10902.
34. [34] Kordower, J.H., Chen, E.Y., Sladek, Jr., J.R. and Mufson, E.J., TRK-immunoreactivity in the monkey central nervous system: Forebrain, J. Comp. Neurol., 349 (1994) 20-35.
35. [35] Kordower, J.H., Charles, V., Bayer, R., Bartus, R.T., Putney, S., Walus, L. and Friden, P.M., Intravenous administration of an NGF conjugate prevents neuronal degeneration in a model of Huntington's disease, Proc. Natl. Acad. Sci., USA 91 (1994) 9077-9080.
36. [36] Kordower, J.H., Mufson, E.J., Granholm, A.C., Hoffer, B. and Friden, P.M., Delivery of trophic factors to the primate brain, Exp. Neurol., 124 (1993) 21-30.
37. [37] Kordower, J.H., Chen, E.Y., Winn, S.R. and Emerich, D.F., Intrastriatal grafts of polymer encapsulated cells genetically modified to secrete human NGF influence cholinergic and noncholinergic striatal neurons, Neuroscience, in press.
38. [38] Kromer, L.F., Nerve growth factor treatment after brain injury prevents neuronal death, Science, 235 (1987) 214-216.
39. [39] Levi-Montalcini, R. and Angeletti, P.U., Nerve growth factor, Physiol. Rev., 8 (1968) 534-569.
40. [40] Lindsay, R.M., Wiegand, S.J., Altar, C.A. and Distephano, P.S., Neurotrophic factors: From molecule to man, Trends Neurosci., 17 (1994) 182-190.
41. [41] Martinez-Serrano, A., Fischer, W. and Björklund, A., Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain, Neuron, 15 (1995b) 1-20.
42. [42] Mesulam, M.-M., Mufson, E.J., Wainer, B.H. and Levey, A.I., Central cholinergic pathways in the rat: An overview based on an alternative nomenclature, Neuroscience, 10 (1983) 1185-1201.
43. [44] Mufson, E.J., Bothwell, M., Hersh, L.B. and Kordower, J.H., Nerve growth factor receptor immunoreactive profiles in the normal aged human basal forebrain: Colocalization with cholinergic neurons, J. Comp. Neurol., 285 (1989) 196-217.
44. [45] Mufson, E.J., Bothwell, M. and Kordower, J.H., Loss of nerve growth factor receptor-immunoreactive neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain, Exp. Neurol., 10 (1989) 221-232.
45. [46] Parada, L.F., Tsoulfas, P., Tessarollo, L., Blair, J., Reid, S.W. and Soppet, D., The trk family tyrosine kinases: Receptors for NGF-related neurotrophins, Cold Spring Harbor Symp. Quant. Biol., 57 (1992) 43-51.
46. [47] Pioro, E.P. and Cuello, A.C., Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system-I. Forebrain, Neuroscience, 34 (1990) 57-87.
47. [48] Pioro, E.P. and Cuello, A.C., Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system-II. Brainstem, cerebellum and spinal cord, Neuroscience, 34 (1990) 89-110.
48. [49] Rosenberg, M.B., Friedman, T., Robertson, R.C., Tuszynski, M., Wolff, J.A., Breakfield, X.O. and Gage, F.H., Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression, Science, 242 (1988) 1575-1578.
49. 3H] GABA in CNS tissue grafts, J. Comp. Neurol., 305 (1991) 676-690.
50. [51] Schumacher, J.M., Short, M.P., Hyman, B.T., Breakefield, X.O. and Isacson, O., Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids, Neuroscience, 45 (1991) 561-570.
51. [52] Schwab, M.E., Otten, U., Agid, Y. and Thoenen, H., Nerve growth factor (NGF) in the rat CNS: Absence of specific retrograde transport and tyrosine hydroxylase induction in locus coeruleus and substantia nigra, Brain Res., 168 (1979) 473-483.
52. [53] Seiler, M. and Schwab, M.E., Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat, Brain Res., 300 (1984) 33-39.
53. [54] Sims, N.R., Bowen, D.M., Allen, S.J., Smith, C.C.T., Neary, D., Thomas, D.J. and Davidson, A.N., Presynaptic cholinergic dysfunction in patients with dementia, J. Neurochem., 40 (1981) 503-509.
54. [55] Sobreviela, T., Clary, D.O., Reichardt, L.F., Brandabur, M.M., Kordower, J.H. and Mufson, E.J., TrkA-immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin, J. Comp. Neurol., 350 (1994) 587-611.
55. [56] Sofroniew, M.V., Pearson, R.C.A. and Powell, T.P.S., The cholinergic nuclei of the basal forebrain of the rat: normal structure, development and experimentally induced degeneration, Brain Res., 371 (1987) 310-331.
56. [57] Sofroniew, M.V. and Pearson, R.C.A., Degeneration of cholinergic neurons in the basal nucleus following kainic or N-methyl-D-aspartic acid application to the cerebral cortex in the rat, Brain Res., 339 (1985) 186-190.
57. [58] Sofroniew, M.V., Pearson, R.C.A.. Eckenstein, F., Cuello, A.C. and Powell, T.P.S., Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage, Brain Res., 289 (1983) 370-374.
58. [59] Steininger, T.L., Wainer, B.H., Klein, R., Barbacid, M. and Palfrey, H.C., High affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat, Brain Res., 612 (1993) 330-335.
59. [60] Strömberg, I., Wetmore, C.J., Ebendal, T., Ernfors, P., Persson, H. and Olson, L., Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF, J. Neurosci. Res., 25 (1990) 405-411.
60. [61] Thoenen, H. and Barde, Y.A., Physiology of nerve growth factor, Physiol. Rev., 60 (1980) 1284-1335.
61. [62] Vazquez, M.E. and Ebendal, T., Messenger RNAs for trk and the low-affinity NGF receptor in rat basal forebrain, Neuroreport, 2 (1991) 593-596.
62. [63] Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T. and DeLong, M.R., Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain, Science, 215 (1992) 1237-1239.
63. [64] Williams, L.R., Varon, S., Peterson, G.M., Wictorian, K., Fisher, W., Björklund, A. and Gage, F.H., Continuous infusion of nerve growth factor prevents basal forebrain neuronal cell death after fimbria-fornix transection, Proc. Natl. Acad. Sci. USA, 83 (1986) 9231-9236.